Search results for "Validation group"

showing 2 items of 2 documents

Regional and experiential differences in surgeon preference for the treatment of cervical facet injuries: a case study survey with the AO Spine Cervi…

2021

Abstract Purpose The management of cervical facet dislocation injuries remains controversial. The main purpose of this investigation was to identify whether a surgeon’s geographic location or years in practice influences their preferred management of traumatic cervical facet dislocation injuries. Methods A survey was sent to 272 AO Spine members across all geographic regions and with a variety of practice experience. The survey included clinical case scenarios of cervical facet dislocation injuries and asked responders to select preferences among various diagnostic and management options. Results A total of 189 complete responses were received. Over 50% of responding surgeons in each region…

Cervical spine; Joint dislocations; Neck injuries; Spinal diseases; Spinal injuries; Traumamedicine.medical_specialtyFacet (geometry)Neck injurieNeuroscience(all)610 Medicine & healthExperiential learningTraumaJoint dislocation03 medical and health sciencesJoint dislocations0302 clinical medicineCervical spineSpinal diseasemedicineHumansOrthopedics and Sports Medicine030212 general & internal medicineJoint dislocation610 Medicine & healthCervical spine ; Joint dislocations ; Neck injuries ; Spinal diseases ; Spinal injuries ; TraumaSurgeonsValidation groupSpinal injuriebusiness.industrySpine.cervicalmedicine.diseasePreferenceNeck injuriesSpinal injuriesSpinal FusionCervical VertebraePhysical therapySurgeryNeurosurgeryAnterior approachbusiness030217 neurology & neurosurgerySpinal diseases
researchProduct

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Gr…

2020

Purpose: For localized, resectable neuroblastoma without MYCN amplification, surgery only is recommended even if incomplete. However, it is not known whether the genomic background of these tumors may influence outcome. Patients and methods: Diagnostic samples were obtained from 317 tumors, International Neuroblastoma Staging System stages 1/2A/2B, from 3 cohorts: Localized Neuroblastoma European Study Group I/II and Children's Oncology Group. Genomic data were analyzed using multi- and pangenomic techniques and fluorescence in-situ hybridization in 2 age groups (cutoff age, 18 months) and were quality controlled by the International Society of Pediatric Oncology European Neuroblastoma (SIO…

OncologyCancer Researchmedicine.medical_specialtyGenomicsNeuroblastomaCogInternal medicineNeuroblastomaHumansMedicineProgression-free survivalSurvival rateNeoplasm StagingChromosome AberrationsClinical Trials as TopicN-Myc Proto-Oncogene ProteinValidation groupbusiness.industryChromosomes Human Pair 11Age FactorsGene AmplificationInfantORIGINAL REPORTSGenomicsPrognosismedicine.diseaseDiploidyProgression-Free SurvivalDoenças GenéticasSurvival RateOncologyPediatric OncologyChromosomes Human Pair 1Mycn amplificationNeoplasm stagingbusinessJournal of Clinical Oncology
researchProduct